SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-094890
Filing Date
2021-03-26
Accepted
2021-03-25 21:00:26
Documents
5
Effectiveness Date
2021-03-26

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ON FORM S-8 d117406ds8.htm S-8 52589
2 EX-5.1 d117406dex51.htm EX-5.1 15721
3 EX-23.1 d117406dex231.htm EX-23.1 1361
4 GRAPHIC g117406g79t65.jpg GRAPHIC 2886
5 GRAPHIC g117406g95a02.jpg GRAPHIC 3777
  Complete submission text file 0001193125-21-094890.txt   80191
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254737 | Film No.: 21774311
SIC: 2834 Pharmaceutical Preparations